clinical_trials
FDA Expands Ryzumvi Approval to Include Presbyopia
Confidence86·multiple reportsImportance88NP-EVT-20261019-B6ADB02
(MedPage Today) -- People with aging-associated farsightedness gained a new topical treatment option as the FDA expanded the approval of phentolamine ophthalmic solution 0.75% (Ryzumvi) to include presbyopia, according to Opus Genetics and Viatris...
Read the original at the primary source
FDA Expands Ryzumvi Approval to Include Presbyopia
10/19/2026, 7:48:09 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —